Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Burkitt Lymphoma × loncastuximab tesirine × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 8 Lymphoma 4 Lymphoma, Follicular 3 Lymphoma, B-Cell 3 Lymphoma, Mantle-Cell 2 Waldenstrom Macroglobulinemia 1 Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 49 Vincristine 31 Prednisone 27 Methotrexate 26 blinatumomab 23 Cytarabine 23 Rituximab 21 Doxorubicin 20 Dexamethasone 20 Etoposide 17 prednylidene 16 merphos 16 deltacortene 16 Mercaptopurine 16 fludarabine 15 Specimen Handling 15 Calcium Dobesilate 14 venetoclax 13 Inotuzumab Ozogamicin 13 CT-P10 13 Biopsy 13 dexamethasone acetate 12 dexamethasone 21-phosphate 12 azathiopurine 12 auricularum 12 fludarabine phosphate 11 N,N-dicyclohexyl-isoborneol-10-sulfonamide 11 Leucovorin 11 pegaspargase 10 Spinal Puncture 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡